| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | TSHR Ab|TSHR antibody|Thyroid Stimulating Hormone Receptor antibody |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target |
Background
mouse TRAb (Thyroid Stimulating Hormone Receptor Antibody) (TSHR) is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.
Biological role and mechanism
The biological role of TRAb is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of TRAb can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
TRAb (Thyroid Stimulating Hormone Receptor Antibody) (TSHR) may also be referenced as TSHR Ab, TSHR antibody, and Thyroid Stimulating Hormone Receptor antibody in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how TRAb relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.
- Interpreting shifts in TRAb levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
TRAb has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Mechanism of Prunella vulgaris L. and luteolin in restoring Tfh/Tfr balance and alleviating oxidative stress in Graves' disease
IF: 6.7 Journal: Phytomedicine Author: Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China; Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, 210028, China. Cited Date: 2024-07-05
PTPN22 through the regulation of Th17/Treg balance acts as a potential target for the treatment of Graves' disease
IF: 2.7 Journal: Tissue and Cell Author: Department of Endocrinology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou,?Fujian 362000,?China. Cited Date: 2024-08-02
TSHR-targeting nucleic acid aptamer treats Graves' ophthalmopathy via novel allosteric inhibition
IF: Journal: bioRxiv Author: State Key Laboratory of Ophthalmology, Optometry and Vision Science, 8 Eye Hospital, Wenzhou Medical University; Wenzhou, 325027, China. Cited Date: 2025-03-28